ENTELLUS MEDICAL INC Research and Development Expense
ENTELLUS MEDICAL INC reported Research and Development Expense of $4.65 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-11-03
- ENTELLUS MEDICAL INC research and development expense for the quarter ending 2017-09-30 was $4.65M, a 127.31% increase year-over-year.
- ENTELLUS MEDICAL INC research and development expense for the quarter ending 2017-06-30 was $2.13M, a 13.45% increase year-over-year.
- ENTELLUS MEDICAL INC research and development expense for the quarter ending 2017-03-31 was $2.10M, a 9.99% increase year-over-year.
- ENTELLUS MEDICAL INC research and development expense for the quarter ending 2016-12-31 was $1.96M, a 41.31% increase year-over-year.
- ENTELLUS MEDICAL INC research and development expense for fiscal 2016 was $7.79M, a 44.64% increase from fiscal 2015.
- ENTELLUS MEDICAL INC research and development expense for fiscal 2015 was $5.39M, a 25.08% increase from fiscal 2014.
- ENTELLUS MEDICAL INC research and development expense for fiscal 2014 was $4.31M, a 16.26% decline from fiscal 2013.
- ENTELLUS MEDICAL INC research and development expense for fiscal 2013 was $5.14M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2017-09-30 | $4.65M 10-Q · filed 2017-11-03 | $6.78M derived: sum of 2 quarters · filed 2017-11-03 | $8.88M 10-Q · filed 2017-11-03 | $10.84M derived: sum of 4 quarters · filed 2017-11-03 |
| 2017-06-30 | $2.13M 10-Q · filed 2017-08-04 | $4.23M 10-Q · filed 2017-08-04 | $6.19M derived: sum of 3 quarters · filed 2017-08-04 | $8.23M derived: sum of 4 quarters · filed 2017-11-03 |
| 2017-03-31 | $2.10M 10-Q · filed 2017-05-05 | $4.06M derived: sum of 2 quarters · filed 2017-05-05 | $6.11M derived: sum of 3 quarters · filed 2017-11-03 | $7.98M derived: sum of 4 quarters · filed 2017-11-03 |
| 2016-12-31 | $1.96M 10-K · filed 2017-02-22 | $4.01M derived: sum of 2 quarters · filed 2017-11-03 | $5.88M derived: sum of 3 quarters · filed 2017-11-03 | $7.79M 10-K · filed 2017-02-22 |
| 2016-09-30 | $2.05M 10-Q · filed 2017-11-03 | $3.92M derived: sum of 2 quarters · filed 2017-11-03 | $5.83M 10-Q · filed 2017-11-03 | $7.22M derived: sum of 4 quarters · filed 2017-11-03 |
| 2016-06-30 | $1.87M 10-Q · filed 2017-08-04 | $3.79M 10-Q · filed 2017-08-04 | $5.17M derived: sum of 3 quarters · filed 2017-08-04 | $6.56M derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | $1.91M 10-Q · filed 2017-05-05 | $3.30M derived: sum of 2 quarters · filed 2017-05-05 | $4.69M derived: sum of 3 quarters · filed 2017-05-05 | $6.00M derived: sum of 4 quarters · filed 2017-05-05 |
| 2015-12-31 | $1.39M 10-K · filed 2017-02-22 | $2.78M derived: sum of 2 quarters · filed 2017-02-22 | $4.09M derived: sum of 3 quarters · filed 2017-02-22 | $5.39M 10-K · filed 2017-02-22 |
| 2015-09-30 | $1.39M 10-K · filed 2017-02-22 | $2.70M derived: sum of 2 quarters · filed 2017-02-22 | $4.00M 10-Q · filed 2016-11-04 | $5.17M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | $1.31M 10-K · filed 2017-02-22 | $2.61M 10-Q · filed 2016-08-04 | $3.78M derived: sum of 3 quarters · filed 2017-02-22 | $4.75M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | $1.30M 10-K · filed 2017-02-22 | $2.47M derived: sum of 2 quarters · filed 2017-02-22 | $3.44M derived: sum of 3 quarters · filed 2017-02-22 | $4.49M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $1.17M 10-K · filed 2016-02-25 | $2.14M derived: sum of 2 quarters · filed 2016-02-25 | $3.19M derived: sum of 3 quarters · filed 2016-02-25 | $4.31M 10-K · filed 2017-02-22 |
| 2014-09-30 | $972.00K 10-K · filed 2016-02-25 | $2.02M derived: sum of 2 quarters · filed 2016-02-25 | $3.13M 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $1.05M 10-K · filed 2016-02-25 | $2.16M 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $1.12M 10-K · filed 2016-02-25 | |||
| 2013-12-31 | $5.14M 10-K · filed 2016-02-25 |